Pharmaceutical Company Novartis announces a 5-year anti-malaria assistance for CameroonPharmaceutical Company Novartis announces a 5-year anti-malaria assistance for Cameroon

By DOH JAMES SONKEY International pharmaceutical company, Novartis has announced a five-year commitment to help Cameroon in the fight against malaria. Announcing this commitment last April 17, 2018, Novartis officials explained that “Through this commitment our company will invest more than USD 100 million to advance research and development of next-generation treatments to combat emerging resistance to artemisinin and other currently used antimalarials.” The announcement came at the time Cameroon was observing a national week in the fight against malaria described by health officials as the number one killer disease especially among pregnant women and children. The commitment includes expanding…